NTI 1.54% 6.6¢ neurotech international limited

Ann: US Clinical Trial Results Published, page-53

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,908 Posts.
    lightbulb Created with Sketch. 390
    Distribution agreements in place in seven countries.
    Product is certified for sale in all of those markets, and more.
    Manufacturing begins within two weeks, distribution beginning within six weeks.

    Why do you say 12 months for "meaningful revenues"?

    The product already has insane levels of awareness. With the study now published the product now has credibility to go with the awareness. My personal expectation is that we will see significant revenues this quarter, with possible positive cash flows from the December quarter.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
0.001(1.54%)
Mkt cap ! $64.55M
Open High Low Value Volume
6.5¢ 6.7¢ 6.5¢ $31.77K 482.5K

Buyers (Bids)

No. Vol. Price($)
1 97000 6.4¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 261563 1
View Market Depth
Last trade - 15.31pm 03/12/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.